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Abstract
Dengue virus (DENV) infections range from asymptomatic or mild illness to a severe and potentially life threatening disease,
dengue hemorrhagic fever (DHF). DHF occurs in primary DENV infections during early infancy. A prospective clinical study of
DENV infections during infancy was conducted in San Pablo, Philippines. We found that infants who developed DHF with a
primary DENV infection had higher WHO weight-for-age z scores before and at the time of infection compared to infants
with primary DENV infections who did not develop DHF. In addition, TLR 7/8-stimulated tumor necrosis factor-a (TNF-a)
production from myeloid-derived cells was higher among well-nourished infants. Leptin augmented TLR 7/8-mediated TNF-
a production in monocytes and decreased intracellular cAMP levels. Circulating leptin levels were elevated during early
infancy and correlated with WHO weight-for-age z scores. Our data support a plausible hypothesis as to why well-nourished
infants are at risk for developing DHF with their first DENV infection.
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Introduction
Dengue is the most prevalent arthropod-borne viral illness in
humans with half of the world’s population at risk. There are up to
50 million cases of dengue estimated each year resulting in
500,000 hospitalizations and 20,000 deaths [1]. The dengue
viruses (DENVs) are single-stranded, positive-sense, RNA-con-
taining enveloped viruses belonging to the Flavivirus genus within
the Flaviviridae family [2]. There are four serotypes of DENVs
(DENV1-4). DENV infections produce a wide spectrum of clinical
illness. It ranges from asymptomatic or mild illness to a severe and
potentially life threatening disease, dengue hemorrhagic fever
(DHF). The global spread of dengue, and the incidence of
epidemic DHF, have increased dramatically over the past 50 years
and continue on an upward trajectory [3,4]. An accurate
understanding of DHF pathogenesis is important for clinicians,
public health officials, and vaccine researchers in dengue affected
countries. DHF occurs almost exclusively in two clinical settings-
children and adults with secondary heterologous DENV infec-
tions, and primary DENV infections during early infancy [3,5,6]
which is the focus of this paper.
Among clinicians, there is an observation that DHF is seen only
in ‘‘chunky’’ babies [7]. In one previous report, infants with low
weight-for-age by Centers for Disease Control (CDC) standards
were underrepresented among DHF cases compared to healthy
controls [6]. In a clinical study of DENV infections in infants, we
found that infants who developed DHF with a primary DENV
infection had higher World Health Organization (WHO) weight-
for-age z scores before and at the time of infection compared to
infants with primary DENV infections who did not develop DHF.
During early infancy, Toll-like receptor (TLR) 7/8-stimulated
tumor necrosis factor-a (TNF-a) production from myeloid-derived
cells was higher among infants with WHO weight-for-age z scores
$22 compared to those with weight-for-age z scores,22. Leptin
augmented TLR 7/8-mediated TNF-a production in monocytes,
and circulating leptin levels were elevated during early infancy and
correlated with WHO weight-for-age z scores. Our data support a
plausible hypothesis as to why well-nourished infants are at risk for
developing DHF with their first DENV infection.
Methods
Ethics Statement
The infant clinical study was approved by the institutional
review boards of the Research Institute for Tropical Medicine,
Philippines, and the University of Massachusetts Medical School.
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e88944
Mothers and their healthy infants were recruited and enrolled
after providing written informed consent.
Clinical Study
Details about the study protocol have been previously described
[8]. Study enrollment began in October 2006 in San Pablo,
Philippines. The clinical study is registered at www.clinicaltrials.
gov (identifier NCT00377754). Healthy infants and their mothers
were enrolled when the infant was between 6–18 weeks old.
Peripheral blood mononuclear cells (PBMC) were collected from
infants at the first study visit, isolated using HistopaqueH density
centrifugation, and cryopreserved. Clinical and epidemiological
information were also collected at the study visits. Infant weight
was measured to the nearest tenth of a kilogram. Infant length was
measured to the nearest centimeter. WHO length-for-age, body
mass index (BMI)-for-age, weight-for-age, and weight-for-length z
scores for study infants were determined using the SPSS macro
provided by WHO [9]. Infants with missing values or biologically
implausible anthropometric z scores were excluded from analyses.
Biologically implausible z scores were length-for-age z score ,26
or .6, BMI-for-age z score ,26 or .6, weight-for-age z score
,26 or .5, or weight-for-length z score ,26 or .6.
Flow cytometry
Infant PBMC from the first study visit were used for
intracellular cytokine staining. PBMC were washed with media,
and then left unstimulated or stimulated with 1 mM R-848
(Invivogen)616 h. The stimulations were done in the presence of
1 ml Brefeldin A (BD Biosciences)616 h. Cells were stained with
LIVE/DEADH Fixable Dead Cell Stain Kit (LDA) (Invitrogen),
fixed and permeabilized with Cytofix/CytopermTM (BD Biosci-
ences), and stained with Abs. Monocytes were identified as LDA-/
CD1c-/CD19-/CD36+/CD123-/CD303- and myeloid DCs were
identified as LDA-/CD1chi/CD19-/CD36-/CD123-/CD303- (all
Abs from eBiosciences). TNF-a, IL-6, and pro-IL-1b production
was measured by staining with the respective mAbs (BD
Biosciences). In some infant PBMC, surface expression of the
leptin receptor (ObR) was determined by staining with an anti-
ObR mAb (BD Biosciences). Cells were analyzed using a
FACSAriaTM flow cytometer (BD Biosciences). Data was analyzed
using FlowJoH software (Treestar).
ELISAs
Leptin levels were measured in infant plasma samples by
ELISA, per the manufacturer’s instructions (R&D Systems).
Samples were assayed in duplicate. PBMC from healthy, non-
obese, male adult donors were collected at the University of
Massachusetts Medical School under a protocol approved by the
institutional review board. CD14+ monocytes were isolated from
these PBMC using MACSH magnetic beads (Miltenyi Biotec). The
CD14+ monocytes were stimulated with R-848 in the presence or
absence of recombinant human leptin (R&D Systems), as
indicated. TNF-a levels in cell-free culture supernatants, and
cAMP levels in cell lysates, were measured by ELISAs, per the
manufacturer’s instructions (R&D Systems).
Statistical Analysis
The SPSS software package (version 20.0) was used for
statistical analyses. Comparisons between continuous variables
were performed using the non-parametric Mann-Whitney U or
Kruskal-Wallis tests, as appropriate. P-values,0.05 were consid-
ered significant. P-values$0.05 and ,0.10 were considered a
significant trend.
Results
Undernourished/malnourished infants have a low risk for
developing DHF with their first DENV infection
As part of a prospective clinical study of DENV infections in
infants, we measured the length and weight of infants in San
Pablo, Laguna, Philippines at two scheduled study visits. We then
calculated WHO anthropometric indices that use these measure-
ments- length-for-age, BMI-for-age, weight-for-age, and weight-
for-length z scores (Figure S1). We identified 74 primary DENV
infections in these infants; 61 were DENV3, 12 were DENV2, and
1 was DENV1. 10 infants with primary DENV infections
developed unambiguous DHF (n=5 DHF Grades III/IV and
n=5 DHF Grades I/II). At the time of their primary DENV
infection, the WHO weight-for-age z scores of infants with DHF
were significantly higher than those with symptomatic DENV
infections and no DHF (Figure 1a). At the first study visit and
before their DENV infections, the WHO weight-for-age z scores of
infants who would go on to develop DHF were also higher than
infants who would not develop DHF with their primary DENV
infection (Figure 1b). None of the other anthropometric indices
were significantly different between the two groups. The
distribution of WHO weight-for-age z scores at study visit 1
among the infants who would not develop DHF with their primary
DENV infection was similar to the entire study infant population
in San Pablo, Philippines (Figure 1b). Our data suggested that a
WHO weight-for-age z score,22 during early infancy (under-
nourished/malnourished state) was associated with a low risk for
developing DHF with a primary DENV infection.
Undernourished/malnourished infants have lower R-848
stimulated monocyte TNF-a production compared to
well-nourished infants
Several immunological deficits have been reported in under-
nourished/malnourished infants and children (WHO weight-for-
age z score,22) [10,11,12]. R-848 is an imidazoquinolone and
synthetic guanosine-like compound that stimulates human TLR
7/8 [13]. Among infants who did not develop DENV infections,
we found that R-848-stimulated TNF-a production in human
monocytes from early infancy was lower in an undernourished/
malnourished state (WHO weight-for-age z score,22) compared
to a well-nourished condition (WHO weight-for-age z score $22)
(Figure 2). A similar finding was seen for circulating myeloid
dendritic cells in early infancy (Figure S2). There were no
significant differences for the other anthropometric indices or
gender. TLR-induced production of interleukin (IL)-6 and pro-IL-
1b was not different between the two groups (data not shown). Our
data suggested that TLR 7/8 stimulation of a pro-inflammatory
cytokine, TNF-a, was impaired in myeloid-derived cells from
infants in an undernourished/malnourished state (WHO weight-
for-age z score,22).
Circulating leptin levels are elevated in early infancy and
a well-nourished state, and decrease over the first year of
life
Leptin is a cytokine produced by adipose tissue [14], and
circulating levels in adulthood correlate with adiposity [15,16,17].
Well nourished neonates and infants are known to have abundant
adipose tissue (‘‘baby fat’’) [18]. We measured plasma leptin levels
in n=38 healthy infants at 3 study visits over the first year of life.
At each study visit, plasma leptin levels were significantly positively
correlated with WHO weight-for-age z scores, but none of the
other anthropometric indices or gender (Study Visit 1: Spearman
Pathogenesis Model Infant Dengue Hemorrhagic Fever
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r=0.41, p= 0.01; Study Visit 2: Spearman r=0.37, p = 0.02;
Study Visit 3: Spearman r=0.38, p = 0.02). Plasma leptin levels
were elevated during early infancy and subsequently decreased
over the first year of life (Figure 3). Our data suggested that
circulating leptin levels correlated with infant adiposity (as
determined by WHO weight-for-age z score) and were elevated
in early infancy and a well-nourished state.
Leptin increases TLR 7/8 stimulated monocyte TNF-a
production and decreases intracellular monocyte cAMP
levels
Human monocytes from early infancy express the leptin
receptor (ObR) (ObR median fluorescence intensity (MFI) in
CD14+ monocytes 49.5 [28.7–80.7], median [95% CI], fluores-
cence-minus-one (FMO) controls subtracted, n=8 infants ages 2.5
[1.7–3.5] months). Adult monocytes also express ObR [19]. In
CD14+ monocytes from non-obese adult male donors, recombi-
nant human leptin augmented R-848-stimulated TNF-a produc-
tion and decreased intracellular cAMP levels (Figure 4).
Discussion
An undernourished/malnourished condition during early
infancy (WHO weight-for-age z score,22) was associated with
a decreased risk for developing DHF with a primary DENV
infection compared to a well-nourished condition. TLR 7/8-
mediated TNF-a production in myeloid-derived cells was also
lower in undernourished/malnourished infants compared to well-
nourished ones. Leptin enhanced TLR 7/8-mediated monocyte
TNF-a production and decreased intracellular cAMP levels. In
Figure 1. World Health Organization (WHO) weight-for-age z scores of infants with primary dengue virus (DENV) infections (a) at
the time of acute illness and (b) at the first study visit, before the primary DENV infection. Boxplot bars are median values, box outlines
are 25th and 75th percentiles, and error bars are 10th and 90th percentiles. Ages are presented as median [95% confidence interval]. { p-values for
primary DENV-infected infants with unambiguous dengue hemorrhagic fever (DHF) compared to those without DHF (non-parametric statistical tests).
doi:10.1371/journal.pone.0088944.g001
Figure 2. Intracellular cytokine staining for tumor necrosis factor-a (TNF-a) production in R-848 (1 mM) stimulated infant peripheral
blood mononuclear cells (PBMC) from the first study visit in an undernourished/malnourished state (WHO weight-for-age (w-a) z
score,22) compared to a well-nourished state (WHO w-a z score$22). Bars are median values. P-values are from non-parametric statistical
tests. (a) Percentage of TNF-a+ monocytes, and (b) TNF-a median fluorescence intensity (MFI) in monocytes. Unstimulated condition subtracted from
the values for each donor.
doi:10.1371/journal.pone.0088944.g002
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infants, circulating leptin levels correlated with WHO weight-for-
age z scores, and the highest leptin levels were seen in a well-
nourished state during early infancy.
The hallmark of DHF is endothelial dysfunction. This
dysfunction is manifested by a vascular leakage syndrome and
sometimes a hemorrhagic diathesis. The morbidity and mortality
Figure 3. Longitudinal assessment of plasma leptin levels in n=38 healthy infants over the first year of life. Symbols and error bars are
median values and 95% confidence intervals.
doi:10.1371/journal.pone.0088944.g003
Figure 4. Effect of leptin pre-treatment on (a) tumor necrosis factor (TNF)-a production and (b) intracellular cAMP levels in CD14+
monocytes. Recombinant human (rh) leptin was added to CD14+ monocytes from non-obese adult male donors 1 h before stimulating with R-848
(5 mM) (n= 6 independent experiments). Cell-free culture supernatants were collected 6 h later for TNF-a ELISAs, and cell lysates were collected for
cAMP ELISAs. Bars and error bars are median values and S.D., respectively. * p = 0.03 compared to no leptin pre-treatment. { p= 0.046 compared to no
leptin pre-treatment.
doi:10.1371/journal.pone.0088944.g004
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of DHF are largely driven by the vascular leakage and its ensuing
complications. In our model, the pathogenesis of DHF (vascular
leakage) is largely determined by a dynamic balance between pro-
inflammatory/pro-angiogenic cytokines (e.g. TNF-a) and type I
interferon-dependent CD73 expression and activity [20]. Leptin
potentiated monocyte TNF-a production. Circulating monocyte
TNF-a production and its leptin potentiation are unlikely to play a
direct role in infant DHF pathogenesis, but are likely to correlate
with similar behavior in other cell types. The leptin receptor can
be found on dendritic cells, endothelial cells, macrophages, and T-
lymphocytes [21,22,23,24]. Any of these cell types or combina-
tions is more likely to play a direct role in infant DHF
pathogenesis. Leptin levels were low in an undernourished/
malnourished state during early infancy and in a well-nourished
state at approximately 1 year of age. Both groups have a low risk
for developing DHF with a primary DENV infection. Leptin levels
were high in a well-nourished state during early infancy, a group at
risk for developing DHF with a primary DENV infection. The
high leptin levels in a well-nourished state during early infancy
presumably reflect adipose tissue accumulation in this age range
[18].
Human neonatal and infant cells have elevated levels of
intracellular cAMP, and increased intracellular cAMP levels
decreased TLR-mediated TNF-a production [25]. Leptin aug-
mented cellular TNF-a production presumably by its ability to
decrease intracellular cAMP levels. Future studies to directly
demonstrate this causal linkage are planned. In our model, leptin-
mediated augmentation of TNF-a production plays a role in the
pathogenesis of infant DHF with primary DENV infections. It
provides a plausible hypothesis to explain the clinical and
epidemiological observations of infant DHF.
Supporting Information
Figure S1 World Health Organization (WHO) anthropo-
metric z scores among infants in San Pablo, Laguna,
Philippines at (a) study visit 1, and (b) study visit 2.
Boxplot bars are median values, box outlines are 25th and 75th
percentiles, and error bars are 10th and 90th percentiles. Ages are
presented as median [95% confidence interval].
(TIF)
Figure S2 Intracellular cytokine staining for tumor
necrosis factor-a (TNF-a) production in R-848 (1 mM)
stimulated infant peripheral blood mononuclear cells
(PBMC) from the first study visit in an undernourished/
malnourished state (WHO weight-for-age (w-a) z score
,22) compared to a well-nourished state (WHO w-a z
score $22). Bars are median values. P-values are from non-
parametric statistical tests. (a) Percentage of TNF-a+ myeloid
dendritic cells (mDCs), and (b) TNF-a median fluorescence
intensity (MFI) in mDCs. Unstimulated condition is subtracted
from the values for each donor.
(TIF)
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